Knight Rider is a modern hybrid-indica strain bred from the crossing of Skywalker and Blue Magoo. The specific history of its development remains undocumented, as there is no central record identifying its original breeder or the circumstances of its creation. As such, the origins of this cultivar are not settled, and its emergence into the market reflects the common trend of complex hybrid development within contemporary breeding circles.

Regarding its chemical composition, the strain features a diverse range of secondary metabolites, with a confirmed terpene profile led by limonene, followed by myrcene, caryophyllene, linalool, beta-pinene, nerolidol, humulene, pinene, camphene, isopulegol, terpinolene, ocimene, bisabolol, gamma-terpinene, and alpha-terpinene. While these compounds are confirmed, the overall impact on the user's sensory experience is supported by an estimated THC content of approximately 20.9 percent. This cannabinoid concentration, combined with its high-diversity terpene profile, provides a specific aromatic and chemical foundation for the strain.

Users typically report that the effects of Knight Rider are focused and relaxed. Given this therapeutic profile, the strain is often sought out as a management tool for pain, stress, and sleep. Cultivators can expect a moderate level of difficulty when growing this strain, which thrives in both indoor and outdoor environments. With an efficient 53-day flowering cycle and a high yield, Knight Rider serves as a functional addition to a garden, though it has not yet produced any recorded or noted offspring.